BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22984126)

  • 1. Successful treatment of Hurthle cell thyroid carcinoma with lung and liver metastasis using docetaxel and cisplatin.
    Zhang H; Zeng L; Liang C; Qiu H; Zhang M; Zhu Y; Xie C
    Jpn J Clin Oncol; 2012 Nov; 42(11):1086-90. PubMed ID: 22984126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel, cisplatin, and fluorouracil for patients with inoperable recurrent or metastatic head and neck squamous cell carcinoma.
    Cho H; Nishiike S; Yamamoto Y; Takenaka Y; Nakahara S; Yasui T; Hanamoto A; Inohara H
    Auris Nasus Larynx; 2015 Oct; 42(5):396-400. PubMed ID: 25721854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intra-arterial infusion chemotherapy for liver metastases of testicular tumors: report of two cases].
    Tanase K; Tawada M; Moriyama N; Muranaka K
    Hinyokika Kiyo; 2000 Nov; 46(11):823-7. PubMed ID: 11193306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in 29 patients with locally advanced follicular or Hürthle cell thyroid carcinoma: a phase 2 study.
    Besic N; Auersperg M; Gazic B; Dremelj M; Zagar I
    Thyroid; 2012 Feb; 22(2):131-7. PubMed ID: 22175241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.
    Jin J; Xu X; Wang F; Yan G; Liu J; Lu W; Li X; Tucker SJ; Zhong B; Cao Z; Wang D
    J Thorac Oncol; 2009 Aug; 4(8):1017-21. PubMed ID: 19542899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of advanced esophageal cancer with liver metastases: efficacy of combination therapy of docetaxel/cisplatin/5-FU].
    Ehara K; Tsutsumi K; Kinoshita Y; Ueno M; Mine S; Udagawa H
    Gan To Kagaku Ryoho; 2008 Aug; 35(8):1375-8. PubMed ID: 18701852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter phase I/II study of docetaxel, cisplatin and fluorouracil combination chemotherapy in patients with advanced or recurrent squamous cell carcinoma of the esophagus.
    Yamasaki M; Miyata H; Tanaka K; Shiraishi O; Motoori M; Peng YF; Yasuda T; Yano M; Shiozaki H; Mori M; Doki Y
    Oncology; 2011; 80(5-6):307-13. PubMed ID: 21778771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil.
    Tsuchiya A; Imai M; Kamimura H; Togashi T; Watanabe K; Seki K; Ishikawa T; Ohta H; Yoshida T; Kamimura T
    World J Gastroenterol; 2009 Apr; 15(14):1779-81. PubMed ID: 19360925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of docetaxel/cisplatin/fluorouracil combination chemotherapy against metastatic esophageal squamous cell carcinoma.
    Takahashi H; Arimura Y; Yamashita K; Okahara S; Tanuma T; Kodaira J; Hokari K; Tsukagoshi H; Shinomura Y; Hosokawa M
    J Thorac Oncol; 2010 Jan; 5(1):122-8. PubMed ID: 19898259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin, cisplatin, and fluorouracil combination therapy for metastatic esophageal squamous cell carcinoma.
    Honda M; Miura A; Izumi Y; Kato T; Ryotokuji T; Monma K; Fujiwara J; Egashira H; Nemoto T
    Dis Esophagus; 2010 Nov; 23(8):641-5. PubMed ID: 20545978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.
    Hironaka S; Yamazaki K; Taku K; Yokota T; Shitara K; Kojima T; Ueda S; Machida N; Muro K; Boku N
    Jpn J Clin Oncol; 2010 Nov; 40(11):1014-20. PubMed ID: 20603245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre phase II study of docetaxel plus cisplatin for the treatment of advanced gastric cancer.
    Fahlke J; Ridwelski K; Schmidt C; Hribaschek K; Stuebs P; Kettner E; Quietzsch D; Assmann M; Deist T; Keilholz U; Lippert H
    Chemotherapy; 2007; 53(6):454-60. PubMed ID: 17957099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemotherapy with triweekly docetaxel and cisplatin followed by concomitant chemoradiotherapy with or without surgery in stage III non-small-cell lung cancer: a phase II study.
    Aydiner A; Sen F; Saglam EK; Oral EN; Eralp Y; Tas F; Toker A; Dilege S
    Clin Lung Cancer; 2011 Sep; 12(5):286-92. PubMed ID: 21729649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of small cell carcinoma of the stomach with multiple liver and lung metastases successfully treated by combined chemotherapy with cisplatin and etoposide].
    Futagami F; Asano K; Matsumura A; Ohhori I; Sasaki M; Kawahara E
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):149-52. PubMed ID: 9987513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases.
    Seto A; Sugitani I; Toda K; Kawabata K; Takahashi S; Saotome T
    Surg Today; 2015 Feb; 45(2):221-6. PubMed ID: 25734195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.
    Betticher DC; Hsu Schmitz SF; Tötsch M; Hansen E; Joss C; von Briel C; Schmid RA; Pless M; Habicht J; Roth AD; Spiliopoulos A; Stahel R; Weder W; Stupp R; Egli F; Furrer M; Honegger H; Wernli M; Cerny T; Ris HB
    J Clin Oncol; 2003 May; 21(9):1752-9. PubMed ID: 12721251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.
    Kwon JH; Kim JH; Lee JA; Shin HC; Kim HJ; Song HH; Jung JY; Kim HY; Choi DR; Kim HS; Park YI; Zang DY
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):889-97. PubMed ID: 20091311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
    Shukuya T; Yamanaka T; Seto T; Daga H; Goto K; Saka H; Sugawara S; Takahashi T; Yokota S; Kaneda H; Kawaguchi T; Nagase S; Oguri T; Iwamoto Y; Nishimura T; Hattori Y; Nakagawa K; Nakanishi Y; Yamamoto N;
    Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of esophageal carcinoma with the lung and liver metastases surviving more than 3 years].
    Sueyama H
    Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1668-72. PubMed ID: 2230449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced gastric cancer with liver and lymph node metastases successfully resected after induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil.
    Cavanna L; Bodini FC; Stroppa EM; Banchini F; Michieletti E; Capelli P; Zangrandi A; Anselmi E
    Chemotherapy; 2014; 60(4):224-7. PubMed ID: 25872022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.